Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
13.95 SEK | -1.41% |
|
-9.12% | +86.00% |
May. 27 | Sweden’s IRLAB Therapeutics Names New CEO | MT |
May. 27 | IRLAB Therapeutics AB Announces CEO Changes, Effective from August 1, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+86.00% | 69.63M | |
+47.13% | 765B | |
-6.76% | 354B | |
+19.16% | 331B | |
+8.54% | 299B | |
+18.74% | 248B | |
-1.84% | 219B | |
+11.06% | 216B | |
+5.07% | 164B | |
-2.57% | 162B |
- Stock Market
- Equities
- IRLAB A Stock
- News IRLAB Therapeutics AB
- Irlab Therapeutics Secures European Patent for Parkinson’s Disease Drug Candidate